Enanta Pharmaceuticals (ENTA) Enterprise Value (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Enterprise Value of -$163.8 million for Q1 2026, up 15.31% year-on-year from -$142.0 million in Q1 2025, and up 11.88% on a QoQ basis from -$185.8 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Enterprise Value data on file, last reported at -$163.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 15.31% year-over-year to -$163.8 million; the trailing twelve-month figure through Mar 2026 stood at -$163.8 million (up 15.31% YoY), and the FY2025 full-year result was -$188.9 million, up 23.9% from the prior year.
- Enterprise Value for Q1 2026 stood at -$163.8 million, up from -$185.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$85.4 million in Q3 2023 and bottomed at -$386.6 million in Q2 2023.
- The 5-year median for Enterprise Value is -$216.7 million (2024), against an average of -$232.2 million.
- The widest annual swing landed in 2023, when Enterprise Value soared 65.74%; it then sank 190.66% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$214.5 million in 2022, then plunged by 57.2% to -$337.2 million in 2023, then surged by 35.73% to -$216.7 million in 2024, then advanced by 14.23% to -$185.8 million in 2025, then gained by 11.88% to -$163.8 million in 2026.
- The last three Enterprise Value figures came in at -$163.8 million (Q1 2026), -$185.8 million (Q4 2025), and -$188.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -163.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -163.77 Mn |
| Dec 31, 2025 | -185.85 Mn |
| Sep 30, 2025 | -188.86 Mn |
| Jun 30, 2025 | -204.11 Mn |
| Mar 31, 2025 | -193.38 Mn |
| Dec 31, 2024 | -216.69 Mn |
| Sep 30, 2024 | -248.19 Mn |
| Jun 30, 2024 | -230.09 Mn |
| Mar 31, 2024 | -300.31 Mn |
| Dec 31, 2023 | -337.15 Mn |
| Sep 30, 2023 | -85.39 Mn |
| Jun 30, 2023 | -386.59 Mn |
| Mar 31, 2023 | -210.08 Mn |
| Dec 31, 2022 | -214.47 Mn |
| Sep 30, 2022 | -249.23 Mn |
| Jun 30, 2022 | -253.29 Mn |
| Mar 31, 2022 | -280.33 Mn |
| Dec 31, 2021 | -259.05 Mn |
| Sep 30, 2021 | -244.00 Mn |
| Jun 30, 2021 | -256.82 Mn |
| Mar 31, 2021 | -375.95 Mn |
| Dec 31, 2020 | -386.20 Mn |
| Sep 30, 2020 | -386.65 Mn |
| Jun 30, 2020 | -370.00 Mn |
| Mar 31, 2020 | -355.26 Mn |
| Dec 31, 2019 | -373.79 Mn |
| Sep 30, 2019 | -335.24 Mn |
| Jun 30, 2019 | -389.25 Mn |
| Mar 31, 2019 | -370.16 Mn |
| Dec 31, 2018 | -345.79 Mn |
| Sep 30, 2018 | -308.73 Mn |
| Jun 30, 2018 | -273.23 Mn |
| Mar 31, 2018 | -256.72 Mn |
| Dec 31, 2017 | -220.44 Mn |
| Sep 30, 2017 | -223.67 Mn |
| Jun 30, 2017 | -192.02 Mn |
| Mar 31, 2017 | -175.57 Mn |
| Dec 31, 2016 | -209.36 Mn |
| Sep 30, 2016 | -210.08 Mn |
| Jun 30, 2016 | -218.47 Mn |
| Mar 31, 2016 | -220.42 Mn |
| Dec 31, 2015 | -179.86 Mn |
| Sep 30, 2015 | -145.04 Mn |
| Jun 30, 2015 | -154.10 Mn |
| Mar 31, 2015 | -165.47 Mn |
| Dec 31, 2014 | -104.02 Mn |
| Sep 30, 2014 | -90.56 Mn |
| Jun 30, 2014 | -95.89 Mn |
| Mar 31, 2014 | -94.77 Mn |
| Dec 31, 2013 | -91.90 Mn |
| Sep 30, 2013 | -101.48 Mn |
| Jun 30, 2013 | -94.55 Mn |
| Mar 31, 2013 | -109.11 Mn |
| Dec 31, 2012 | -20.74 Mn |
| Sep 30, 2012 | -43.76 Mn |
| Jun 30, 2012 | -3.96 Mn |
| Mar 31, 2012 | -20.70 Mn |